Reported results
- Q3 diluted EPS (GAAP measure) was $4.94, compared to $4.77 in the third quarter of 2025.
- Q3 adjusted diluted EPS (non-GAAP measure) was $5.91, compared to $5.17 in the third quarter of 2025.
- Q3 net sales (GAAP measure) were $1,872.5 million, an increase of 25% compared to the third quarter of 2025.
- Q3 operating margin (GAAP measure) was 21.8%, compared to 22.0% in the third quarter of 2025.
- Q3 adjusted operating margin (non-GAAP measure) was 25.5%, compared to 23.9% in the third quarter of 2025.
- Q3 free cash flow (non-GAAP measure) was $280.4 million, compared to $253.8 million in the third quarter of 2025.
Guidance
- Full year 2026 total sales growth expected to be 18-19%, including organic sales growth of 10-11%.
- Full year 2026 GAAP diluted earnings per share expected in the range of $17.30 to $17.50.
- Full year 2026 adjusted diluted earnings per share expected in the range of $20.40 to $20.60.
- Full year 2026 free cash flow conversion expected to be approximately 90% on adjusted net income.
Price and volatility reaction
The stock moved -5.5% on the print. No front-expiry chain was on file, so there is no straddle expected move. 30-day ATM implied volatility moved -4.0 vol points across the event (constant-maturity series — not the front-week crush).
| Measure | Value | Basis |
|---|---|---|
| Close before release | 459.4 | 2026-10-26 |
| Close after release | 434.28 | 2026-10-27 |
| Realised move | -5.5% | close to close |
| 30d ATM IV change | -4.0 vol pts | constant-maturity series, not the front expiry |
Source
The figures above come from the earnings release the company filed with the SEC on 2026-10-27 (8-K, Item 2.02). Read the original filing on sec.gov.
